Express Pharma

PCIM&H appoints Dr Raman Mohan Singh as Director

Singh has taken over the charge from Professor VK Prajapati, Director (I/c), PCIM&H, Ghaziabad, effective 1st November, 2022

0 605

The Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) has appointed Dr Raman Mohan Singh as the new Director, a statement from PCIM&H has notified.

Singh has taken over the charge from Professor VK Prajapati, Director (I/c), PCIM&H, Ghaziabad, effective 1st November, 2022.

“In pursuance to Ministry of AYUSH, Order No.Y11011/01/2022-LP-(PCIM&H) dated 29.09.2022 and vide his relieving order No. 4(83)-CDTL-MUM/22-23/4752, dated 31.10.2022, Dr Raman Mohan Singh has taken over the charge from Prof. (Vd.) P.K. Prajapati, Director, I/c, PCIM&H, Ghaziabad in the forenoon of 1st November, 2022 for the post of Director, Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H), Ghaziabad,” noted the statement.

Apart from it, PCIM&H, in collaboration with the World Health Organization-South East Asia Region (WHO-SEARO) has taken a major stride to upgrade laboratory capacity for quality control of tradition/herbal products in South East Asia region. In this regard, a three-day training programme was inaugurated by Pramod Kumar Pathak, Special Secretary, Ministry of AYUSH, in presence of Dr Kim Sungchol, Regional Adviser, Traditional Medicine, WHO-SEARO; Dr Raman Mohan Singh, Director, PCIM&H and other dignitaries, on 1st November, 2022.

A total of 23 participants from nine countries (Bhutan, Indonesia, India, Sri Lanka, Thailand, Nepal, Maldives, Timor Leste and Bangladesh) participated in this training programme. The objective of the training is to impart skills for laboratory-based techniques and methods to maintain the quality of traditional/herbal products.

Speaking on the occasion, Pathak said, “As per the Research and Information System Centre for Developing Countries report, the industry is projected to reach $23.3 billion in 2022. With increasing market, the quality issues of herbal material is also becoming increasingly worrying due to adulteration. The uniformity in lab-based quality control will be able to evaluate quality of the herbals often altered by various physical, chemical and geographical aspects.”

Adding to it, Dr Sungchol said, “WHO-SEARO has successfully organised regional workshops and training for other countries. One of the key recommendations that were made by member countries during these regional workshops was to ensure regulatory capacity and that is why we are organising this first training session in collaboration with PCIM&H, Ministry of AYUSH.”

- Advertisement -